FRI085 Lipid Lowering Therapy Deficits In Secondary Cardiovascular Prevention In A Large Cohort From Eight Busy Clinics In Greece Over 12 Years

Disclosure: R.D. Paparodis: None. I. Androulakis: None. D.P. Askitis: None. I. Perogamvros: None. N. Angelopoulos: None. A. Rizoulis: None. S. Livadas: None. A. Boniakos: None. Background: The increasing availability of aggressive lipid lowering therapies (LLTs) worldwide is expected to produce a si...

Descripción completa

Detalles Bibliográficos
Autores principales: Paparodis, Rodis D, Androulakis, Ioannis, Askitis, Dimitrios P, Perogamvros, Ilias, Angelopoulos, Nikolaos, Rizoulis, Andreas, Livadas, Sarantis, Boniakos, Anastasios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Cardiovascular Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555229/
http://dx.doi.org/10.1210/jendso/bvad114.599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555229/
http://dx.doi.org/10.1210/jendso/bvad114.599

Ejemplares similares